Document Type : Original Article


1 Human Cytogenetics and Genomics Laboratory, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, 603103, Kelambakkam, Tamilnadu, India

2 Department of Neurology, Chettinad Super speciality Hospital, Chettinad Health City, 603103, Kelambakkam, Tamilnadu, India


Background: Migraine is a multifactorial neurological disorder characterized by frequent moderate to severe intensity headaches. The genetic variations in synaptic and post-receptor signalling proteins have direct effect on the process of serotonergic neurotransmission.
Methods: We aimed to investigate the genetic association of serotonin transporter (SERT) 5-hydroxytryptamine transporter-linked promoter region (5-HTTLPR) polymorphism and migraine risk in South-Indian population. A total of 304 subjects with migraine including with aura (MA) and without aura (MO) and 308 controls were included in the present study. The single nucleotide polymorphism (SNP) was detected using polymerase chain reaction (PCR) and confirmed by deoxyribonucleic acid (DNA) sequencing.
Results: The genotyping analysis revealed insignificant relationship with migraine subjects when compared with controls (P > 0.05). The minor ‘S’ allele showed no association with odds ratio (OR) = 1.23 [95% confidence interval (CI): 0.90-1.66], heterozygote with OR = 1.18 (95% CI: 0.82-1.69), and homozygote with OR = 1.51 (95% CI: 0.52-4.35).
Conclusion: Further clinical studies are required to validate the results of SERT 5-HTTLPR promoter polymorphism in diverse ethnic descents especially in Asian populations.


  1. Yang Y, Ligthart L, Terwindt GM, Boomsma DI, Rodriguez-Acevedo AJ, Nyholt DR. Genetic epidemiology of migraine and depression. Cephalalgia 2016; 36(7): 679-91.
  2. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859): 2163-96.
  3. Kowalska M, Kapelusiak-Pielok M, Grzelak T, Wypasek E, Kozubski W, Dorszewska J. The New *G29A and G1222A of HCRTR1, 5-HTTLPR of SLC6A4 Polymorphisms and Hypocretin-1, Serotonin Concentrations in Migraine Patients. Front Mol Neurosci 2018; 11: 191.
  4. Vecsei L, Majlath Z, Balog A, Tajti J. Drug targets of migraine and neuropathy: Treatment of hyperexcitability. CNS Neurol Disord Drug Targets 2015; 14(5): 664-76.
  5. van de Ven RC, Kaja S, Plomp JJ, Frants RR, van den Maagdenberg AM, Ferrari MD. Genetic models of migraine. Arch Neurol 2007; 64(5): 643-6.
  6. Meng W, Adams MJ, Hebert HL, Deary IJ, McIntosh AM, Smith BH. A genome-wide association study finds genetic associations with broadly-defined headache in UK Biobank (N=223,773). EBioMedicine 2018; 28: 180-6.
  7. Sicuteri F. Headache as possible expression of deficiency of brain 5-hydroxytryptamine (central denervation supersensitivity). Headache 1972; 12(2): 69-72.
  8. Jacobs B, Dussor G. Neurovascular contributions to migraine: Moving beyond vasodilation. Neuroscience 2016; 338: 130-44.
  9. Borroni B, Brambilla C, Liberini P, Rao R, Archetti S, Gipponi S, et al. Functional serotonin 5-HTTLPR polymorphism is a risk factor for migraine with aura. J Headache Pain 2005; 6(4): 182-4.
  10. Gasparini CF, Smith RA, Griffiths LR. Genetic and biochemical changes of the serotonergic system in migraine pathobiology. J Headache Pain 2017; 18(1): 20.
  11. Bartlett JE, Kotrlik JW, Higgins CC. Organizational research: Determining appropriate sample size in survey research. Inf Technol Learn Perform J 2001; 19(1): 43-50.
  12. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd Cephalalgia 2004; 24(Suppl 1): 9-160.
  13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16(3): 1215.
  14. Aswathi R, Viji D, Pricilla Charmine PS, Akram Husain RSR, Noorul Ameen SH, Ahmed SS, et al. Influence of KCNJ11 gene polymorphism in T2DM of south Indian population. Front Biosci (Elite Ed) 2020; 12(2): 199-222.
  15. Ghosh J, Joshi G, Pradhan S, Mittal B. Investigation of TNFA 308G > A and TNFB 252G > A polymorphisms in genetic susceptibility to migraine.
    J Neurol 2010; 257(6): 898-904.
  16. Shyti R, de Vries B, van den Maagdenberg A. Migraine genes and the relation to gender. Headache 2011; 51(6): 880-90.
  17. Stewart WF, Staffa J, Lipton RB, Ottman R. Familial risk of migraine: A population-based study. Ann Neurol 1997; 41(2): 166-72.
  18. Nordquist N, Oreland L. Serotonin, genetic variability, behaviour, and psychiatric disorders--a review. Ups
    J Med Sci 2010; 115(1): 2-10.
  19. Corominas R, Sobrido MJ, Ribases M, Cuenca-Leon E, Blanco-Arias P, Narberhaus B, et al. Association study
    of the serotoninergic system in migraine in the Spanish population. Am J Med Genet B Neuropsychiatr Genet 2010; 153B(1): 177-84.
  20. Gonda X, Rihmer Z, Juhasz G, Zsombok T, Bagdy G. High anxiety and migraine are associated with the s allele of the 5HTTLPR gene polymorphism. Psychiatry Res 2007; 149(1-3): 261-6.
  21. Lesch KP. Serotonin transporter: from genomics and knockouts to behavioral traits and psychiatric disorders. In: Briley M, Sulser F, editors. Molecular genetics of mental disorders. London: Martin Dunitz Publishers; 2001. p. 221-67.
  22. Kotani K, Shimomura T, Shimomura F, Ikawa S, Nanba E. A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks. Headache 2002; 42(9): 893-5.
  23. Kim WK, Kim HS, Kim WJ, Lee KY, Park H, Kim CH, et al. Serotonin transporter gene polymorphism and migraine in the Korean population. Headache 2005; 45(8): 1056-60.
  24. Racchi M, Leone M, Porrello E, Rigamonti A, Govoni S, Sironi M, et al. Familial migraine with aura: Association study with 5-HT1B/1D, 5-HT2C, and hSERT polymorphisms. Headache 2004; 44(4): 311-7.
  25. Wieser T, Dresler K, Evers S, Gaul C, Konig D, Holzl D, et al. No influence of 5-HTTLPR gene polymorphism on migraine symptomatology, comorbid depression, and chronification. Headache 2010; 50(3): 420-30.
  26. Liu H, Liu M, Wang Y, Wang XM, Qiu Y, Long JF, et al. Association of 5-HTT gene polymorphisms with migraine: A systematic review and meta-analysis. J Neurol Sci 2011; 305(1-2): 57-66.
  27. Juhasz G, Zsombok T, Laszik A, Gonda X, Sotonyi P, Faludi G, et al. Association analysis of 5-HTTLPR variants, 5-HT2a receptor gene 102T/C polymorphism and migraine. J Neurogenet 2003; 17(2-3): 231-40.
  28. Schurks M, Rist PM, Kurth T. 5-HTTLPR polymorphism in the serotonin transporter gene and migraine: a systematic review and meta-analysis. Cephalalgia 2010; 30(11): 1296-305.
  29. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of migraine. Neuroscience 2009; 161(2): 327-41.